The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy

European Urology, Supplements

Volumn 6, Issue 10, 2007, Pages 641-645

  Brinkmann, Olaf A ^a   Semik, Michael ^a   Gosherger, Georg ^a   Hertle, Lothar ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Immunotherapy; Metastases; Renal cell carcinoma; Surgery

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL; INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CAPILLARY LEAK SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; IMMUNOTHERAPY; KIDNEY CARCINOMA; MALE; METASTASIS; NAUSEA; PRIORITY JOURNAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WOUND INFECTION;

EID: 34247193110     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2007.03.003     Document Type: Article

References (16)

1. Elson P.J., Witte R.S., and Trump D.L. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 46 (1998) 7310-7313
2. Bukowski R.M. Natural history and therapy of metastatic renal cell carinoma. The role of Interleukin-2. Cancer 80 (1997) 1198-1220
3. Figlin R.A. Renal cell carcinoma: management of advanced disease [review article]. J Urol 161 (1999) 381-387
4. Novick A.C., and Campbell S.C. Renal tumors. In: Walsh P.C., Retik A.B., Vaughan E.D., et al. (Eds). Campbell's urology (2002), WB Saunders, Philadelphia 2672-2731
5. van der Poel H.G., Roukema J.A., Horenblas S., et al. Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol 35 (1999) 197-203
6. Mickisch G.H.J., Garin A., van Poppel H., et al., members of the European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group. Radical nephrectomy plus interferon alfa based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358 (2001) 966-970
7. Flanigan R.C., Salmon S.E., Blumenstein B.A., et al. Nephrectomy followed by interferon alpha-2b compared with interferon alpha-2b alone for metastatic renal-cell cancer. Engl J Med 345 (2001) 1655-1659
8. Kim B., and Louie A.C. Surgical resection following interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission. Arch Surg 127 (1992) 1343-1349
9. Sherry R.M., Pass H.I., Rosenberg S.A., et al. Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy. Cancer 69 (1992) 1850-1855
10. Sella A., Swanson D.A., Ro J.Y., et al. Surgery following response to interferon-alpha-based therapy for residual renal cell carcinoma. J Urol 149 (1993) 19-21
11. Kierney P.C., van Heerden J.A., Segura J.W., et al. Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review. Ann Surg Oncol 1 (1994) 345-352
12. Tanguay S., Swanson D.A., and Putnam Jr. J.B. Renal cell carcinoma metastatic to the lung: potential benefit in the combination of biological therapy and surgery. J Urol 156 (1996) 1586-1589
13. Krishnamurthi V., Novick A.C., and Bukowski R.M. Efficacy of multimodality therapy in advanced renal cell carcinoma. Urology 51 (1998) 933-937
14. Figlin R.A., Pierce W.C., Kaboo R., et al. Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor. J Urol 158 (1997) 740-745
15. Motzer R.J., and Russo P. Systemic therapy for renal cell carcinoma. J Urol 163 (2000) 408-417
16. Fyfe G., Fisher R.I., Rosenberg S.A., et al. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol 13 (1995) 688-696